(Q40476933)

English

Intranasal immunization with a replication-deficient adenovirus vector expressing glycoprotein H of murine cytomegalovirus induces mucosal and systemic immunity.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Intranasal immunization with a replication-deficient adenovirus vector expressing glycoprotein H of murine cytomegalovirus induces mucosal and systemic immunity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Cytomegalovirus

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

John D Shanley

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Carol A Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

996-1003

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Human cytomegalovirus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

The Pathogenesis of Pneumonitis Due to Murine Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Characterization of virus-induced interferon-gamma responses in mice previously infected with murine cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Expression of the Glycoprotein H of Murine Cytomegalovirus and Identification of an N-terminal Antibody-Binding Region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

The pathogenicity of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Antibodies to human cytomegalovirus structural polypeptides during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Modification by Adoptive Humoral Immunity of Murine Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

Epidemiology of cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.041

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.07.041

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40476933&oldid=1775317811"